Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates

L Corash - Vox Sanguinis, 2000 - Wiley Online Library
Substantial increments in the safety of blood transfusion have been achieved through
continued improvements in donor testing, yet residual concern about the safety of blood …

Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates

L Corash - Vox sanguinis, 1998 - Wiley Online Library
Despite the increased safety of blood achieved through continued improvements in donor
testing, concern remains about the safety of blood components. Transfusion of cellular …

Inactivation of infectious pathogens in labile blood components: meeting the challenge

L Corash - Transfusion clinique et biologique, 2001 - Elsevier
Substantial improvement in the safety of blood transfusion has been achieved through the
addition of new tests, such as nucleic acid tests, yet residual risk associated with transfusion …

Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: current research perspectives

L Corash - Transfusion medicine reviews, 1999 - Elsevier
LTHOUGH increased safety of blood components has been achieved through continued
improvements in donor testing, concern remains about the safety of blood products. A recent …

New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes

L Corash - Best Practice & Research Clinical Haematology, 2000 - Elsevier
Despite the increased safety of blood components, achieved through improved donor
selection and testing, transfusion recipients remain at risk of transfusion-associated …

Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections

J McCullough - American journal of clinical pathology, 2007 - academic.oup.com
Remarkable improvements have been made in blood safety since the onset of the HIV
epidemic. However, the current paradigm does not prevent all transfusion-transmitted …

Pathogen reduction technology: methods, status of clinical trials, and future prospects.

L Corash - Current Hematology Reports, 2003 - europepmc.org
Transfusion-transmitted infections caused by viruses, bacteria, and protozoa have been
extensively reported for the past three decades. In the early 1980s, the HIV epidemic …

Progress in improving the pathogen safety of red cell concentrates

J Chapman - Vox sanguinis, 2000 - Wiley Online Library
Current methods of preparing red cell concentrates do not include a process step to
decontaminate pathogens potentially present in the transfusion product. Although …

Pathogen inactivation technologies for cellular blood components: an update

P Schlenke - Transfusion Medicine and Hemotherapy, 2014 - karger.com
Nowadays patients receiving blood components are exposed to much less transfusion-
transmitted infectious diseases than three decades before when among others HIV was …

Transmission of parasites and bacteria by blood components

RY Dodd - Vox sanguinis, 2000 - Wiley Online Library
Background and Objectives: Although most attention has been paid to viral infections as a
complication of transfusion, some parasitic infections are readily transmissible and generate …